NCT04803006View on ClinicalTrials.gov

A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA)

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2030

Conditions
Kidney Transplantation
Interventions
BIOLOGICAL

TCD601

Investigational Product

Trial Locations (2)

10032

Columbia University Irving Medical Center, New York

94143

UCSF Connie Frank Transplant Center, San Francisco

All Listed Sponsors
lead

ITB-Med LLC

INDUSTRY